EPISODE · Oct 8, 2024 · 29 MIN
Life Science REIT (LABS)
from JohnBaronPortfolios.co.uk · host John Hughman
LABS is a real estate investment trust focused on delivering strong total returns from a portfolio of properties leased to tenants operating in the UK life science sector. The company buys and develops properties specifically in the so-called Golden Triangle of Oxford, Cambridge, and King’s Cross in London - the beating heart of the UK’s world-leading life science industries. In this interview we speak to manager Simon Farnsworth about the advantages of having a specialist focus in real estate; how the specific demands of life science tenants create greater opportunity to unlock value through asset management of its estate; how the company balances acquisition and development in regions facing extreme planning challenges; and why government support for UK life sciences and the proximity to leading academic institutions in its target regions is creating a long-term tailwind.
What this episode covers
LABS is a real estate investment trust focused on delivering strong total returns from a portfolio of properties leased to tenants operating in the UK life science sector. The company buys and develops properties specifically in the so-called Golden Triangle of Oxford, Cambridge, and King’s Cross in London - the beating heart of the UK’s world-leading life science industries. In this interview we speak to manager Simon Farnsworth about the advantages of having a specialist focus in real estate; how the specific demands of life science tenants create greater opportunity to unlock value through asset management of its estate; how the company balances acquisition and development in regions facing extreme planning challenges; and why government support for UK life sciences and the proximity to leading academic institutions in its target regions is creating a long-term tailwind.
NOW PLAYING
Life Science REIT (LABS)
No transcript for this episode yet
Similar Episodes
Mar 4, 2026 ·7m
Feb 22, 2026 ·9m
Feb 8, 2026 ·11m
Feb 2, 2026 ·12m
Jan 30, 2026 ·31m